Homo Sildenafil

CAS No. 642928-07-2

Homo Sildenafil( —— )

Catalog No. M24657 CAS No. 642928-07-2

Homo Sildenafil is an analog of Sildenafil, It acts as a phosphodiesterase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 272 In Stock
10MG 408 In Stock
25MG 672 In Stock
50MG 945 In Stock
100MG 1278 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Homo Sildenafil
  • Note
    Research use only, not for human use.
  • Brief Description
    Homo Sildenafil is an analog of Sildenafil, It acts as a phosphodiesterase inhibitor.
  • Description
    Homo Sildenafil is an analog of Sildenafil, It acts as a phosphodiesterase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    phosphodiesterase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    642928-07-2
  • Formula Weight
    488.6
  • Molecular Formula
    C23H32N6O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jackie D Corbin, et al. Vardenafil: Structural Basis for Higher Potency Over Sildenafil in Inhibiting cGMP-specific phosphodiesterase-5 (PDE5). Neurochem Int. 2004 Nov;45(6):859-63.
molnova catalog
related products
  • Oglemilast

    Oglemilast (GRC-3886) is a potent and selective PDE4 inhibitor with IC50 of 2.5 and 1.7 nM for PDE4B and PDE4D, respectively.

  • MK-0873

    MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.

  • PF-04957325

    PF-04957325 is a potent and selective inhibitor of PDE8.PF-04957325 has an IC50 of 0.7 nM for PDE8A and 0.3 nM for PDE8B.PF-04957325 can be used to study autoimmune encephalomyelitis.